BioCentury
ARTICLE | Financial News

Koch joins OrbiMed as venture partner

May 5, 2016 1:45 AM UTC

OrbiMed named Kevin Koch a venture partner. He was SVP of drug discovery for chemical and molecular therapeutics at Biogen Inc. (NASDAQ:BIIB). Before that, Koch was president and CSO of cancer company...